Abstract:Circular RNAs (circRNAs) represent a recently described category of novel, single stranded ribonucleic acid (ssRNA) abundantly represented in the eukaryotic transcriptome. Non‐polyadenylated and intrinsically resistant to exonucleolytic attack, circRNAs are a highly stable ssRNA species significantly enriched in human brain and retinal tissues. The biological evolution and function of most central nervous system (CNS) circRNAs, however, remains poorly understood. Established methods of ssRNA detection and quantitation that require a free 3′ or 5′ ribonucleotide end may have significantly underestimated circRNA abundance and importance in CNS function in both health and disease. One highly represented circRNA in the human brain and retina is a ~1400 nucleotide (nt) ciRS‐7 that contains about ~70 tandem anti‐miRNA‐7 sequences; ciRS‐7 thereby acts as a kind of endogenous, competing, anti‐complementary miRNA inhibitor or “sponge” to adsorb, and hence quench, the normal function(s) of miRNA‐7 (hsa‐miRNA‐7‐1; 23 nt; chr 9q21.32). Using DNA and miRNA arrays, RNA‐sequencing, enhanced LED‐Northern, ELISA and Western blot hybridization, the circularity‐sensitive probe RNaseR, energy of association ( E A ) indexing and miRNA‐mRNA bioinformatics algorithms, we here provide initial evidence of a mis‐regulated miRNA‐7‐anti‐miRNA‐7‐circRNA system in sporadic Alzheimer's disease (AD) brain. Deficits in ciRS‐7, and ciRS‐7 “sponging activities” might be expected to increase ambient miRNA‐7 levels in AD‐affected tissues, as is observed, and these ultimately contribute to the down‐regulation of selective miRNA‐7‐sensitive messenger RNA (mRNA) targets. We report here that the up‐regulation of ambient miRNA‐7 in AD brain, due to a deficiency in ciRS‐7 and ciRS‐7‐mediated “sponging” effects, in turn down‐regulates several AD‐relevant mRNA targets and their expression, including the ubiquitin conjugase protein (UBE2A; miRNA‐7‐UBE2A mRNA 3′UTR E A = −22.9 kcal/mol) and the epidermal growth factor receptor (EGFR; miRNA‐7‐EGFR mRNA 3′UTR E A = −23.2 kcal/mol). UBE2A (chr Xq24; ~17kDa), a central effector in the ubiquitination cycle that helps to orchestrate the clearance of amyloid peptides via phagocytosis, is depleted in sporadic AD brain and retina and contributes to amyloidogenesis. Similarly, decreased levels of the transmembrane glycoprotein EGFR (chr 7p11.1; ~134kDa) found in AD appears to be linked to deficits in brain cell proliferation, cytoskeletal rearrangement and angiogenesis. Our conceptual understanding of the highly specialized functions for non‐coding ssRNA such as circRNAs in the human CNS continues to evolve and their presence and activities underscore the increasing complexity of miRNA‐mRNA‐mediated genetic regulatory networks. Support or Funding Information Research on miRNA signaling in the Lukiw laboratory involving the innate‐immune response in AD, AMD and in other forms of neurological or retinal disease, amyloidogenesis, ubiquitination, synaptogenesis and brain inflammation was supported through an unrestricted grant to the LSU Eye Center from Research to Prevent Blindness (RPB); the Louisiana Biotechnology Research Network (LBRN) and NIH grants NEI EY006311 and NIA AG038834 (WJL).

Identification of Pathological Pathways Centered on Circrna Dysregulation in Association with Irreversible Progression of Alzheimer’s Disease

Identification of pathological pathways centered on circRNA dysregulation in association with irreversible progression of Alzheimer's disease

Comprehensive Analysis of Dysregulated Circular RNAs and Construction of a Cerna Network Involved in the Pathology of Alzheimer’s Disease in a 5 × FAD Mouse Model

Comprehensive analysis of dysregulated circular RNAs and construction of a ceRNA network involved in the pathology of Alzheimer's disease in a 5 × FAD mouse model

CircRNA-ceRNA Network Revealing the Potential Regulatory Roles of CircRNA in Alzheimer’s Disease Involved the Cgmp-Pkg Signal Pathway

Characterization of Circrna-Associated-cerna Networks in a Senescence-Accelerated Mouse Prone 8 Brain.

Whole Transcriptome Sequencing of Peripheral Blood Identifies the Alzheimer's Disease-Related circRNA-miRNA-lncRNA Pathway

The Role of circRNAs in the Pathological Mechanisms of Alzheimer's Disease and May Serve as Potential Biomarkers

Circular RNA Cwc27 contributes to Alzheimer's disease pathogenesis by repressing Pur-alpha activity

Systematic Characterization of Circular RNA-Associated CeRNA Network Identified Novel circRNA Biomarkers in Alzheimer's Disease

Identification of circRNAs linked to Alzheimer's disease and related dementias

Circ-Bptf Ameliorates Learning and Memory Impairments via the miR-138-5p/p62 Axis in APP/PS1 Mice

Circular RNA Cwc27 contributes to Alzheimer’s disease pathogenesis by repressing Pur-α activity

P4‐006: DEFICITS IN THE NATURAL CIRCULAR RNA (CIRCRNA) ‘SPONGE’ FOR MIRNA‐7 (CIRS7) IN ALZHEIMER'S DISEASE (AD): MIRNA‐7 UP‐REGULATION, AND DOWN‐REGULATION OF THE KEY PHAGOCYTOSIS PROTEIN UBIQUITIN LIGASE A (UBE2A)

mRNA and circRNA mislocalization to synapses are key features of Alzheimer's disease

A Circular Rna (circrna) Cirs-7 in Alzheimer'S Disease (ad) Targets Mirna-7 Trafficking and Promotes Deficits in the Expression of the Ubiquitin Conjugase (ube2a) and the Epidermal Growth Factor Receptor (Egfr)

Differential Methylation of Circrna M6a in an APP/PS1 Alzheimer's Disease Mouse Model.

Screening of Human Circular RNAs As Biomarkers for Early Onset Detection of Alzheimer's Disease.

Functional Roles of Circular RNAs in Alzheimer’s Disease

Loss of age-accumulated circRNAs ameliorate amyloid β-induced toxicity in a model for Alzheimer’s disease

Hsa_circ_0049472 contributed to amyloid-beta peptide-induced neurotoxicity, apoptosis and inflammation via regulating PI3K-AKT signaling pathway by interacting with miR-22-3p/ZNF217 axis